DrugPatentWatch Database Preview
Teduglutide recombinant - Generic Drug Details
see a sample report or, see our see our flat-rate plans
What are the generic drug sources for teduglutide recombinant and what is the scope of teduglutide recombinant freedom to operate?
Teduglutide recombinant
is the generic ingredient in one branded drug marketed by Nps Pharms Inc and is included in one NDA. There are twenty-one patents protecting this compound. Additional information is available in the individual branded drug profile pages.There is one drug master file entry for teduglutide recombinant. One supplier is listed for this compound.
Summary for teduglutide recombinant
| US Patents: | 21 |
| Tradenames: | 1 |
| Applicants: | 1 |
| NDAs: | 1 |
| Drug Master File Entries: | 1 |
| Suppliers / Packagers: | 1 |
| Bulk Api Vendors: | 1 |
| Clinical Trials: | 22 |
| Formulation / Manufacturing: | see details |
| Patent Litigation and PTAB cases: | See patent lawsuits and PTAB cases for teduglutide recombinant |
| DailyMed Link: | teduglutide recombinant at DailyMed |
Pharmacology for teduglutide recombinant
| Ingredient-type | Glucagon-Like Peptide 2 Analogs/Derivatives |
| Drug Class | GLP-2 Analog |
| Mechanism of Action | Glucagon-like Peptide-2 (GLP-2) Agonists |
Synonyms for teduglutide recombinant
| BDBM50183895 |
| CHEBI:72305 |
| CHEMBL2104987 |
| revestive |
US Patents and Regulatory Information for teduglutide recombinant
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Nps Pharms Inc | GATTEX KIT | teduglutide recombinant | POWDER;SUBCUTANEOUS | 203441-001 | Dec 21, 2012 | RX | Yes | Yes | ➤ Sign Up | ➤ Sign Up | ➤ Sign Up | ||||
| Applicant | Tradename | Generic Name | Dosage | NDA | Approval Date | TE | Type | RLD | RS | Patent No. | Patent Expiration | Product | Substance | Delist Req. | Exclusivity Expiration |
see a sample report or, see our see our flat-rate plans
see a sample report or, see our see our flat-rate plans
International Patents for teduglutide recombinant
| Country | Document Number | Estimated Expiration |
|---|---|---|
| European Patent Office | 1988100 | ➤ Sign Up |
| European Patent Office | 2009024 | ➤ Sign Up |
| China | 1244872 | ➤ Sign Up |
| Country | Document Number | Estimated Expiration |
Supplementary Protection Certificates for teduglutide recombinant
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
|---|---|---|---|
| 2013 00012 | Denmark | ➤ Sign Up | |
| 13/006 | Ireland | ➤ Sign Up | PRODUCT NAME: TEDUGLUTIDE; REGISTRATION NO/DATE: EU/1/12/787/001 20120830 |
| 3 | Finland | ➤ Sign Up | |
| Supplementary Protection Certificate | SPC Country | SPC Expiration | SPC Description |
For more information try a trial or see the plans and pricing
Serving hundreds of leading biopharmaceutical companies globally:
Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.
ISSN: 2162-2639
Privacy and Cookies
Terms & Conditions
Site Map
Major Patent Expirations 2018 - 2019
Friedman, Yali. "DrugPatentWatch" DrugPatentWatch, thinkBiotech, 2018, www.DrugPatentWatch.com.
Follow DrugPatentWatch: